Roche and BioLamina have signed an agreement to jointly research and develop new cell culture systems for applications, including stem cell research. The collaboration will focus on assessing laminin-based in-vitro cell culture matrices offering highly physiological microenvironments for living cells. Roche will provide R&D funding and scientific expertise to BioLamina. Financial details were not disclosed.   “Our aim is to develop laminin-based culture systems that provide biologically rele...